Reference : Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited b...
Scientific journals : Article
Human health sciences : Neurology
Social & behavioral sciences, psychology : Neurosciences & behavior
Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan
Pardutz, A. [> > > >]
Szatmari, E. [> > > >]
Vecsei, L. [> > > >]
Schoenen, Jean mailto [Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie]
Blackwell Science
Yes (verified by ORBi)
[en] nitroglycerin ; nitric oxide synthase ; caudal spinal trigeminal nucleus ; sumatriptan ; lysine acetylsalicylate
[en] Systemic administration of nitroglycerin (NTG), a nitric oxide (NO) donor, in migraineurs triggers after several hours an attack of which the precise mechanisms are unknown. We found previously in rats that nitroglycerin (10 mg/kg s.c.) is able to increase significantly after 4 h the number of neuronal nitric oxide synthase (nNOS)-immunoreactive neurones in the cervical part of trigeminal nucleus caudalis. In the present experiments, we demonstrate that the 5-HT1(B/D) agonist sumatriptan (0.6 mg/kg s.c.) does not alter this phenomenon when given before NTG. By contrast, pretreatment with lysine acetylsalicylate (50 mg/kg i.m.) attenuates the NTG-induced nNOS expression in the superficial laminae of trigeminal nucleus caudalis. These findings suggest that effect of NTG on nNOS at a high dosage may involve the cycloxygenase pathway and that activation of the peripheral 5-HT1(B/D) receptors is not able to modify this effect. These data could help to better understand the role of NO in the pathogenesis of headaches and the action of antimigraine drugs.

File(s) associated to this reference

Fulltext file(s):

Restricted access
Nitroglycerin-induced in NOS Pardutz et al 04.pdfPublisher postprint155.45 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.